CC
NXTM

CQS Cayman’s NxStage Medical Inc. NXTM Stock Holding History

CQS Cayman’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-21,500
Closed -$534K – 133
2018
Q1 		$534K Buy
21,500
+4,000
+23% +$97.3K 0.02% 118
2017
Q4 		$424K Buy
+17,500
New +$461K 0.03% 100

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

CQS Cayman's NXTM Position: Q2 2018 in Review

CQS Cayman sold out of NxStage Medical Inc. (NXTM) in Q2 2018, closing a stake of 21,500 shares — an estimated $534K sold.

CQS Cayman first reported a position in NXTM in Q4 2017 and held it in 2 quarters. The position peaked at $534K in Q1 2018. 171 funds tracked by Wall St. Rank hold NXTM as of Q2 2018.

  • CQS Cayman reported no remaining NxStage Medical Inc. position as of Q2 2018 after selling out during the quarter.
  • CQS Cayman sold 21,500 NxStage Medical Inc. shares in Q2 2018, an estimated $534K.
  • CQS Cayman first reported a position in NxStage Medical Inc. in Q4 2017 and held it in 2 quarters.
  • CQS Cayman's NxStage Medical Inc. position peaked at $534K in Q1 2018.
  • 171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q2 2018.

Based on CQS Cayman's 13F filing for Q2 2018, filed 13 Aug 2018.